Invicta Diagnostic IPO: Check date, price band, lot size, timeline and key details

Invicta Diagnostic IPO: PC Diagnostics chain operator Invicta Diagnostic will launch its ₹28.12-crore initial public offering on December 1. The issue will conclude on December 3, and the bidding for anchor investors will take place on November 28.

The initial share sale is only a fresh issuance of 33,08,800 shares without any offer for sale (OFS) component. The price band has been fixed at ₹80 to ₹85 per share.

Of the fresh issue proceeds, ₹21.11 crore will be utilised for buying medical equipment for setting up five new diagnostic centres in Maharashtra. A part will also be used for corporate general purposes.

Invicta Diagnostic IPO: Lot size

A lot consists of 1,600 shares. The minimum investment for an individual investor is 3,200 shares. Half of the net offer has been reserved for qualified institutional buyers, 35% for retail investors and the remaining 15% for non-institutional investors.

Invicta Diagnostic IPO: Allotment and listing date

Jeena Sikho Lifecare's founder and managing director, Acharya Manish Grover, holds a 1.37% stake in Invicta Diagnostic.

According to the red herring prospectus (RHP), the company offers a range of around 60 routine and 487 specialised pathology tests and about 96 basic and 130 advanced radiology tests that cover a range of specialties and disciplines.

On the financial front, Invicta Diagnostic reported a revenue of ₹16.94 crore and profit after tax (PAT) of ₹4.08 crore in the quarter ended September 2025. The company posted a revenue of ₹30.09 crore and PAT of ₹4.92 crore in FY25.

The company's shares are proposed to be listed on the NSE Emerge platform.

Socradamus Capital Pvt Ltd is the sole book-running lead manager for the IPO.